Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease

Comment

Jack C de la Torre. N Engl J Med. 2014.

. 2014 Apr 10;370(15):1459-60.

doi: 10.1056/NEJMc1402193.

No abstract available

Comment in

Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.
Doody RS, Farlow M, Aisen PS; Alzheimer’s Disease Cooperative Study Data Analysis and Publication Committee. Doody RS, et al. N Engl J Med. 2014 Apr 10;370(15):1460. doi: 10.1056/NEJMc1402193. N Engl J Med. 2014. PMID: 24716687 No abstract available.
Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.
Salloway S, Sperling R, Brashear HR. Salloway S, et al. N Engl J Med. 2014 Apr 10;370(15):1460. doi: 10.1056/NEJMc1402193. N Engl J Med. 2014. PMID: 24724181 No abstract available.

Antiamyloid therapy for Alzheimer's disease--are we on the right road?
Karran E, Hardy J. Karran E, et al. N Engl J Med. 2014 Jan 23;370(4):377-8. doi: 10.1056/NEJMe1313943. N Engl J Med. 2014. PMID: 24450897 No abstract available.